Email a Friend
Printer Friendly
Slashdot It!
Submit to Reddit
Add to Facebook

New discoveries from Harvard and Baylor get to the heart of cardiovascular disease

June 19, 2008

Even if you eat right and exercise regularly, chances are high that you'll still die of a heart attack or stroke. But thanks to new findings by researchers from Harvard and Baylor, the odds may finally shift in your favor. Two unrelated studies recently published online in The FASEB Journal (http://www.fasebj.org) describe findings on atherosclerosis that have the potential to save millions of lives.

Both studies involved experiments in mice, but cover biological processes present in humans. In the first, scientists from Harvard explain how the absence of a single protein, called "ROCK1," profoundly reduces inflammation in the walls of blood vessels provoked by fatty deposits (atherosclerosis). In this study, scientists found that ROCK1 is necessary for immune cells, called macrophages, to "clean up" vascular walls when they come into contact with fatty deposits. Inflammation is a normal byproduct of the clean-up process and, when it goes unchecked, leads to clogging and hardening of the arteries. When ROCK1 is absent, macrophages no longer contributed to these fatty deposits and mice showed significantly less inflammation and atherosclerosis. This discovery could lead to new treatments, such as ROCK1 inhibitors, that could dampen the inflammatory response to fatty deposits and slow the progression of atherosclerosis, and in so doing, reduce the incidence of heart attacks and strokes.

According to James Liao, MD, Director of Vascular Medicine Research, Brigham and Women's Hospital, Harvard Medical School, and one of the report's co-authors, "the ultimate goal of the research is to prevent or slow atherosclerosis, and these findings provide a new target to do this."

While the first study works to prevent inflammation by keeping cells of the immune system at bay, the second report focuses on the body's ability (or inability) to "cool down" inflammation after this clean-up machinery kicks into high gear. Separate researchers from Harvard, Brigham and Women's Hospital and Baylor looked at how we prevent inflammation from running amok. The scientists identified lipid mediators that the body uses to resolve inflammation once it has started. By targeting these lipid mediators and the mechanisms used to make them, scientists should be able to develop drugs that significantly reduce the inflammation that underlies much of atherosclerosis.

"The specific chemical mediators that naturally cool down the inflammatory process identified in this study represent a new drug target for anti-atherosclerosis therapy," said Aksam Merched, PhD, Assistant Professor at Baylor College of Medicine and the first author of the study. "It's also noteworthy that aspirin stimulates the body to produce one class of these chemicals."

"Even if we delay the process by exercise and rabbit food, sooner or later our blood vessels rot," said Gerald Weissmann, MD, Editor-in-Chief of The FASEB Journal. "Now that we appreciate that atherosclerosis is inflammation gone awry, we can attack its root causes. Studies like these take us closer to delaying the inevitable, and help us understand the factors that provoke heart attacks and strokes."

And as the first study aims to prevent atherosclerosis before the immune system kicks into gear and the second aims to prevent it after the immune system is activated, a third study appearing on the cover of the June 2008 print issue of The FASEB Journal (www.fasebj.org) discusses a new approach toward repairing the damage using artificial grafts that may heal into the natural arteries and blood vessels as time goes on. Find out more about this by visiting The FASEB Journal online at www.fasebj.org and clicking "Press Room."

According to the U.S. Centers for Disease Control and Prevention, heart disease is the number one killer of Americans and a major cause of disability. About 29 percent of all U.S. deaths are from heart disease (approximately 700,000 a year). Stroke is the leading cause of disability in the United States and the third leading cause of death. By reducing the incidence of atherosclerosis, the risk of fatal heart attacks or strokes would decrease significantly.

Federation of American Societies for Experimental Biology

Related Atherosclerosis Current Events and Atherosclerosis News Articles

Atherosclerosis Current Events and Atherosclerosis News RSS

Inhibiting fatty acids in immune cells decreases atherosclerosis risk
Scientists at Washington University School of Medicine in St. Louis have found a way to significantly reduce atherosclerosis in mice that does not involve lowering cholesterol levels or eliminating other obesity-related problems.

Protein important in diabetes may also play a key role in heart disease, other disorders
Studying a protein already known to play an important role in type 2 diabetes and cancer, genomics researchers have discovered that it may have an even broader role in disease, particularly in other metabolic disorders and heart disease.

Replacing hydrogen in fluorescent dyes improves detection ability, stability and shelf life
By swapping out one specific hydrogen atom for an isotope twice as heavy, researchers have increased the shelf life and detection ability of fluorescent probes that are essential to studying a variety of inflammatory diseases, including cancer and atherosclerosis.

Cholesterol's other way out
Many of us are simply overloaded with cholesterol, and now a report in the July issue of Cell Metabolism brings what might be good news: There is more than one way to get rid of that cholesterol, which can otherwise lead to atherosclerosis and heart disease.

Study sheds light on triglyceride metabolism
New findings reported in the July issue of Cell Metabolism, a Cell Press publication, are offering new leads as to why some people might suffer from high levels of triglycerides. High triglycerides are a risk factor for atherosclerosis and cardiovascular disease.

Antagonizing atherosclerosis
Antibody-producing B cells promote atherosclerosis in mice, according to a study to be published online on July 5th in the Journal of Experimental Medicine.

Virgin olive oil and a Mediterranean diet fight heart disease by changing how our genes function
Everyone knows olive oil and a Mediterranean diet are associated with a lower risk for cardiovascular disease, but a new research report published in the July 2010 print issue of the FASEB Journal offers a surprising reason why: These foods change how genes associated with atherosclerosis function.

Experimental nonsteroidal treatment of asthma shows promise
A new nonsteroidal, anti-inflammatory therapy made from a human protein significantly decreases disease signs of asthma in mice, opening the possibility of a new asthma therapy for patients who do not respond to current steroid treatments.

Wining and dining your way to better eyesight
Current research suggests that resveratrol, a naturally occurring compound found in red wine, grapes, blueberries, peanuts, and other plants, inhibits pathogenic new blood vessel growth.

Ingredient in red wine may prevent some blinding diseases
Resveratrol - found in red wine, grapes, blueberries, peanuts and other plants - stops out-of-control blood vessel growth in the eye, according to vision researchers at Washington University School of Medicine in St. Louis.

More Atherosclerosis Current Events and Atherosclerosis News Articles

	Atherosclerosis: Molecular and Cellular Mechanisms by Sarah Jane George (Editor), Jason Johnson (Editor) Covering the most devastating disease in the Western world, this handbook and ready reference provides a comprehensive account of the different stages and factors in the development of the atherosclerotic plaque. Each chapter is written by experts in the field and highlights the role of specific mediators of atherosclerotic plaque development, as well as potential therapeutic targets. A large amount of this up-to-date information is conveyed by way of tables and schematic figures, in a readily comprehensible manner. A must-have for master and PhD students, researchers, MDs and lecturers in vascular biology and cardiology, as well as for academics and scientists in the pharmaceutical industry.
	Dyslipidemia and Atherosclerosis Essentials 2009 by Christie M. Ballantyne (Author), James H. O'Keefe (Author), Antonio M. Gotto (Author) The World's Leading Experts Provide all the 'Essentials' Needed to Manage Patients in the Office, on the Ward, and in the Intensive Care Unit! Written by key opinion leaders in the field of cardiology, Dyslipidemia Essentials integrates the latest clinical guidelines and trials into a practical step-by-step guide to the management of dyslipidemia. Important clinical trials, common management pitfalls, and other cardiovascular risk reduction measures are also emphasized. Topics include: Step-by-step guide to intensive LDL lowering; NCEP ATP III and AHA/ACC guideline Updates; Treatment of low HDL cholesterol and elevated triglyceride; 73 dyslipidemia trials and 17 drug summaries
	Unclog Your Arteries : How I Beat Atherosclerosis by Gene McDougall (Author) Heart attack or bypass surgery? - or even if not- if you are overweight, have high blood pressure, high blood sugar, diabetes, high cholesterol, heart disease, or a family history of any, read this and then keep it for reference.
	Atherosclerosis: Diet and Drugs by Springer This book gives an overview on important mechanisms involved in atherosclerosis and thereby presents targets some of which are used and others which may be useful for therapy and prevention of atherosclerosis. Since atherosclerosis is a multifactorial disease the scientifc approach must be multidisciplinary. Accordingly, the authors of this book represent different areas of methodology ranging from basic, clinical and population research as well as different fields of expertise ranging from metabolism to immunology and inflammation biology and to vascular biology.
	Journal of Atherosclerosis and Thrombosis by Japan Publications Trading Co
	Molecular Mechanisms of Atherosclerosis by Joseph Loscalzo (Editor) Atherosclerosis is the most common cardiovascular disorder in western societies and is rapidly becoming similarly prevalent in the underdeveloped world. Written by notable authorities and providing text rich in illustrative figures, Molecular Mechanisms in Atherosclerosis addresses the fundamental mechanisms underlying atherothrombosis and delineates current views of the molecular and cellular basis of the process. The editor approaches the issue from a mechanistic perspective, and does so in the context of contemporary knowledge of molecular and cellular pathobiology. The book provides an epidemiological overview of atherosclerotic vascular disease, followed by a review of the genetics and genetic epidemiology. It focuses on the four fundamental mechanisms common to all risk...
	Glucose-Balance - Sale! Dr. Kang's formula for use in treating diabetes mellitus and prevents damage of heart;liver;kidney and atherosclerosis from diabetes. Limited time offer. by Trilight,Inc. From the Western scientific perspective, diabetes mellitus is an inherited endocrine disorder characterized by a variable degree of carbohydrate intolerance and specific vascular lesions (i.e., thickening of the capillary basement membrane.) The endocrine aspect of this disease is the lack of sufficient pancreatic insulin to take up nutrients from the blood, in particular, glucose. The short term danger would then be a sort of tissue starvation leading to rapid fat metabolism leading to ketoacidosis and ultimately to metabolic acidosis, shock and death. The long term dangers involve vascular lesions beginning in the lower extremities and fundus of the eye leading to tissue death, loss of sight and limb amputation. In the short term, immediate symptoms include thirst, hunger and frequent...
	Atlas of Atherosclerosis : Risk Factors and Treatment by Scott M. Grundy (Editor) (Author) This new edition is an intergral source of information covering topics such as newer coronary risk factors, high- density lipoprotein metabolism, lipid-lowering drugs, endothelium and thrombosis in atherogenesis, and contributing risk factors. With over 500 exceptional photographs, diagrams, and charts, each chapter illustrates an improtant facet of diagnosing and treating this common and often fatal disease.
	Transeophageal Echo Aorta with Heavy Atherosclerosis Photographic Poster Print, 12x16 by AllPosters.com Transeophageal Echo Aorta with Heavy Atherosclerosis is digitally printed on archival photographic paper resulting in vivid, pure color and exceptional detail that is suitable for any museum or gallery display. Finding that perfect piece to match your interest and style is easy and within your budget!
	Ujimoritoku Ryokucha Sencha Green Tea Blended with Matcha Green Tea Powder - 27 Pyramid Tea Bags (2.85 Oz) by Ujinotsuyu To prepare Hot tea: use 8 Oz hot water. wait until color changed. To prepare cold iced tea: use 2 Oz hot water, wait until color change and add 6 Oz cold water and ice cube. Resealable zip bag. Every tea is mad from same plant camellia sinensis How it is processed is the difference among black tea, green tea or other teas. Green tea contains several polyphenolic compounds that give tea its characteristic taste, flavor and color. The most significant polyphenols present in green tea are catechins, which are very beneficial antioxidants, and said to have following health benefit: Reduce incidence of cancer, tumors Lowers cholesterol, blood pressure Fights cariogenic bacteria, influenza virus